Alkeon Capital Management - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 83 filers reported holding RELMADA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,621,000
+63.7%
100,000
+100.0%
0.00%
+100.0%
Q2 2021$1,601,000
-9.1%
50,0000.0%0.00%
-33.3%
Q1 2021$1,761,000
+9.8%
50,0000.0%0.00%0.0%
Q4 2020$1,604,00050,0000.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders